MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$69,005K
Loss before income
tax expense
-$69,005K
Loss from operations
-$45,641K
Total other (expense)
income
-$23,364K
Interest income
$6,995K
Total operating
expenses
$45,641K
Other (expense)
income, net
-$30,359K
Loss on sale of
in-process research and...
$30,000K
Research and development
$60,411K
General and
administrative
$15,230K
Back
Back
Income Statement
source: myfinsight.com
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)